Insiders · Profile

Erlander Mark

Chief Executive Officer at Cardiff Oncology. Filing since 14 Dec 2016. CIK 0001651537

Company
Date
Role
Action
Shares
Amount
Of holding
25 Nov 2022
Chief Executive Officer
Bought
10,000
$14.30K
69.1%
23 Mar 2021
Chief Executive Officer
Bought
965
$9.98K
7.1%
14 May 2020
Chief Executive Officer
Bought
6,993
$10.00K
110%
14 Dec 2016
Chief Scientific Officer
Bought
5,000
$10.38K
opened
4 decisions on file.